We are live on
!
Find out more
TGIA
Torrey Growth & Income Advisors Portfolio holdings
AUM
$294M
1-Year Est. Return
37.95%
This Fund
S&P 500
This Quarter
Est. Return
-13.83%
1 Year Est. Return
+37.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$239M
AUM Growth
-$48.9M
(-17%)
Cap. Flow
+$396K
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
59.75%
Holding
117
New
7
Increased
35
Reduced
30
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.64M |
| 2 |
Trade Desk
TTD
|
+$1.04M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$848K |
| 4 |
Pfizer
PFE
|
+$497K |
| 5 |
Intellia Therapeutics
NTLA
|
+$428K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$1.54M |
| 2 |
American Express
AXP
|
+$1.34M |
| 3 |
Williams Companies
WMB
|
+$545K |
| 4 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$465K |
| 5 |
TEM
Tempus AI
TEM
|
+$296K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 60.28% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 6.35% |
| 4 | Consumer Discretionary | 4.59% |
| 5 | Consumer Staples | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TJX Companies
TJX
$178B
| $226K | 0.09% |
1,436
| – | – |
|
102
Coca-Cola
KO
$374B
| $220K | 0.09% |
2,900
| – | – |
|
103
Enterprise Products Partners
EPD
$82.6B
| $216K | 0.09% |
+5,600
| New | +$198K |
|
104
TSMC
TSM
$2.17T
| $212K | 0.09% |
+645
| New | +$222K |
|
105
Illinois Tool Works
ITW
$84.9B
| $205K | 0.09% |
+800
| New | +$218K |
|
106
JPMorgan Chase
JPM
$951B
| $200K | 0.08% |
692
+15
| +2% | +$4.55K |
|
107
UiPath
PATH
$7.68B
| $137K | 0.06% |
12,310
+200
| +2% | +$2.55K |
|
108
Comstock
LODE
$247M
| $111K | 0.05% |
36,613
+7,344
| +25% | +$24K |
|
109
Spero Therapeutics
SPRO
$72.4M
| $37.6K | 0.02% |
17,025
| – | – |
|
110
BioAtla
BCAB
$5.69M
| $2.36K | ﹤0.01% |
314
| – | – |
|
111
CrowdStrike
CRWD
$217B
| – | – |
-2,000
| Closed | -$234K |
|
112
Walt Disney
DIS
$181B
| – | – |
-1,835
| Closed | -$209K |
|
|
DOCU
113
DocuSign
DOCU
$11.4B
| – | – |
-4,086
| Closed | -$279K |
|
|
EXAS
114
DELISTED
Exact Sciences
EXAS
| – | – |
-15,156
| Closed | -$1.54M |
|
|
115
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| – | – |
-2,250
| Closed | -$465K |
|
116
Alphabet (Google) Class C
GOOG
$4.33T
| – | – |
-684
| Closed | -$215K |
|
117
Pinterest
PINS
$13.2B
| – | – |
-10,400
| Closed | -$269K |
|
Similar funds
PC
SM
BIC
TJHA
CA
PCI
DMBA
MEPT
Torrey Growth & Income Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Torrey Growth & Income Advisors held 117 positions worth $239M, down 17% from $288M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Torrey Growth & Income Advisors's Q1 2026 filing shows 7 new, 35 increased, 30 reduced and 7 closed positions. Its largest new stake was ImmunityBio: 55,450 shares worth $405K. The largest sale was Exact Sciences, an estimated $1.54M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, down from 63% a quarter earlier, followed by Healthcare and Financials.
- Torrey Growth & Income Advisors's largest Q1 2026 buy was ImmunityBio: 55,450 shares worth $405K.
- Torrey Growth & Income Advisors added most to Salesforce in Q1 2026, an estimated $1.64M increase.
- Torrey Growth & Income Advisors's biggest Q1 2026 reduction was American Express, cutting an estimated $1.34M.
- Torrey Growth & Income Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $1.54M.
- Torrey Growth & Income Advisors's ten largest holdings make up 60% of its $239M portfolio in Q1 2026.
- Torrey Growth & Income Advisors opened 7 new positions and closed 7 in Q1 2026.
- Torrey Growth & Income Advisors's portfolio value fell 17% quarter-over-quarter to $239M.
Based on Torrey Growth & Income Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.